Concepedia

Publication | Open Access

Pilot Study of Hyperfractionated Dosing of Lutetium-177–Labeled Antiprostate-Specific Membrane Antigen Monoclonal Antibody J591 (177Lu-J591) for Metastatic Castration-Resistant Prostate Cancer

DOIFull Paper Access

36

Citations

8

References

2020

Year

Muhammad Junaid Niaz, Jaspreet S. Batra, Ryan D. Walsh, Marigdalia K. Ramirez‐Fort, Shankar Vallabhajosula, Yuliya Jhanwar, Ana M. Molina, David M. Nanus, Joseph R. Osborne, Neil H. Bander,
The Oncologist

Abstract

Hyperfractionation of <sup>177</sup> Lu-J591 is feasible but does not seem to have significant advantages over the two-dose fractionation regimen.

References

YearCitations

Page 1